S

06955

Shandong Boan Biotechnology

13.76

5.52+66.99%
Closed16:08 04/17 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE8.320/8.240
TODAY RANGE8.240-25.000
VOL30.50M
MARKET CAP7.37B
52 WEEK RANGE7.510-25.000
AVG VOL (3M)983.64K
% TURNOVER5.69%
TURNOVER448.18M
P/E (TTM)93.307
% RANGE203.40%
EPS(TTM)0.147
P/E(FORWARD)49.747
P/B4.154
BVPS3.313
DIVIDEND--
P/S10.717
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.37B
SHARES OUTSTANDING535.93M
NEXT EARNINGS--
FREE FLOAT535.93M
LOT SIZE200
EX-DIV DATE--
Same Industry
Name/Symbol
Change%
Price

S

Shandong Boan Biotechnology

06955

+66.99%
13.760

A

Amgen

04332

--

C

China Conch Venture Holdings

00586

+4.23%
7.640

W

Wuxi Apptec

02359

+1.66%
51.950

A

Asymchem Laboratories (Tianjin)

06821

+2.13%
43.100

S

Sinopharm Group

01099

+0.91%
17.760

G

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

+0.36%
16.580

L

Livzon Pharmaceutical Group

01513

+0.58%
25.850

S

Shanghai Pharmaceuticals Holding

02607

+0.19%
10.820

S

Shanghai Fosun Pharmaceutical (Group)

02196

+1.16%
13.980

C

China Medical System Holdings

00867

+1.52%
7.350

S

SciClone Pharmaceuticals (Holdings)

06600

0.00%
18.720

W

Wuxi Biologics (Cayman)

02269

+1.49%
20.500

C

China Isotope & Radiation

01763

-0.18%
11.160

C

China Shineway Pharmaceutical Group

02877

0.00%
7.570

T

The United Laboratories International Holdings

03933

-0.94%
12.680

C

Consun Pharmaceutical Group

01681

-0.84%
9.460

3

3SBio

01530

-0.83%
11.960

S

Shandong Xinhua Pharmaceutical

00719

+0.37%
5.440

B

Beijing Tong Ren Tang Chinese Medicine

03613

+0.71%
8.480

C

China Resources Pharmaceutical Group

03320

+0.41%
4.870
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.